Jennifer L. Taubert, EVP, WW Chair, Pharmaceuticals at JOHNSON & JOHNSON (JNJ), sold 120,707 shares at $156.27 ($18.9M) on 2024-02-09, disclosed to the SEC on 2024-02-12.
Seasonal sale ($18.9M) by EVP, WW Chair, Pharmaceuticals — this insider has traded JNJ in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $156.33 | 1,913 | $299K | 1.6% |
| 2 | $156.27 | 59,397 | $9.3M | 49.2% |
| 3 | $156.27 | 59,397 | $9.3M | 49.2% |
| Total | $156.27 avg | 120,707 | $18.9M | 100% |
| Filing → |
| JNJ | SELL | 2022-11-23 | $27.2M | — | Filing → |